batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Iovance’s lung cancer hold proves short lived 4 March 2024 Inhibrx cans co-stimulatory candidate 29 February 2024 No purple patch for Purple Biotech 28 February 2024 Legend investors hope EU endorsement is good omen 26 February 2024 After a long review tislelizumab makes EU progress 26 February 2024 Roche begins another pivotal Skyscraper study 21 February 2024 The next Keytruda vs Jemperli battle 20 February 2024 Head and neck cancer up next for Jemperli 19 February 2024 Load More